Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

New technique finds bacteria to increase the vitamin B2 content of soya drinks

Researchers at DTU have developed a new method that can reduce the time needed to find new bacteria for fermentation. They have now identified a bacterium that can be used both for acidification and to increase the vitamin B2 content of soya drinks. A new meth

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Researchers at DTU have developed a new method that can reduce the time needed to find new bacteria for fermentation. They have now identified a bacterium that can be used both for acidification and to increase the vitamin B2 content of soya drinks.

A new method developed by researchers at the DTU National Food Institute can speed up the process of identifying bacteria that can be used both for fermentation and to increase the vitamin B2 content in soya drinks. In the study, the microbiome (the complete bacterial community) from bumblebees was examined and tested in microscopic droplets for its ability to produce vitamin B2.

Our research shows that it is possible to screen entire microbial communities directly and rapidly, and that promising bacteria can be identified from environmental samples without prior isolation and analysis of individual bacteria. This can make the development of new starter cultures faster and more targeted." Claus Heiner Bang-Berthelsen, Associate Professor, DTU National Food Institute

The research has been published in the scientific journal LWT - Food Science and Technology.

Researchers have discovered promising bacteria in bumblebees

The study addresses a problem common to many plant-based dairy alternatives: they contain fewer vitamins and minerals than cow's milk. One of the nutrients typically lacking is vitamin B2 (riboflavin).

The researchers therefore set out to quickly identify bacteria that could both thrive in soya drinks and produce vitamin B2 themselves during fermentation. They used bacteria from bumblebee guts as a starting point for screening potential vitamin B2-producing strains.

"Bumblebees live close to plants, and their guts contain many microorganisms that are already adapted to plant-based environments. That is why it was interesting for us to test whether we could find bacteria in bumblebees capable of producing vitamin B2 in soya drinks," says Postdoc Hang Xiao from the DTU National Food Institute.

Tested the bacteria in microscopic droplets

In the study, the researchers applied an existing technology known as 'droplet screening' in a new way.

"Unlike conventional agar plate-based methods for microbial cultivation and screening, we encapsulated the bee gut bacteria in microscopic droplets so that each droplet contained only one bacterium and acted as an enclosed culture chamber. In this way, the individual bacterium could be analyzed at ultra-high speed by using our microfluidics screening platform, enabling us to screen millions of bacterial cells within just a few hours," says Hang Xiao.

Ordinary soya drinks are often cloudy and full of particles, which can interfere with measurements. To make droplet screening compatible with soy-based drinks, the researchers developed a highly transparent soy medium.

"By making the soya liquid transparent, we were able to both screen the bacteria in an environment resembling their future application and, at the same time, obtain more stable droplets and more precise measurements," says Claus Heiner Bang-Berthelsen.

The bacteria were first exposed to roseoflavin, a substance structurally like riboflavin that can promote the growth of the bacteria best suited to producing vitamin B2. The researchers then selected the droplets that glowed the brightest, as high fluorescence indicates high vitamin B2 production.

"This droplet-based microbial screening approach saved months of work and significantly reduced the resource use compared with conventional screening methods," says Claus Heiner Bang-Berthelsen.

A particular Lactococcus lactis strain stood out

Among the bacteria identified, one lactic acid bacterium proved particularly interesting. When the researchers tested the bacterium in real plant-based products, it proved especially effective in soya drinks:

"The results suggest that the bacterium works not only under laboratory conditions, but also in actual foods containing a significant amount of protein," says Hang Xiao.

It turned out that the bacterium continued to produce vitamin B2 in soya drinks even at high levels of added (fortified) vitamin B2, demonstrating robust and stable production.

The bacterium was also found to be capable of utilizing many different types of sugar. This makes it an interesting candidate for use as a starter culture in plant-based fermentation processes, as it is not restricted to a single, very narrow substrate.

It generally performed less well in rice and oat drinks, as well as in some almond drinks, which the researchers attribute to their low protein content. Their interpretation is that the bacterium requires a certain level of fermentable protein to grow well and produce vitamin B2 effectively.

"The exciting thing about the method is that it can not only identify vitamin B2-producing bacteria in soya drinks. It can also be adapted to identify other interesting substances, provided they can be detected using fluorescence. However, the method only works if the medium is transparent and has a low fluorescence background," says Hang Xiao.

Xiao, H., et al. (2026). Droplet microfluidics-based isolation, adaptation, and screening of riboflavin-producing lactic acid bacteria for fermenting plant-based dairy alternatives. DOI: 10.1016/j.lwt.2026.119036. https://www.sciencedirect.com/science/article/pii/S0023643826000460

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Could daraxonrasib be effective against other cancer types?

RAS mutations are one of the most common cancer-causing genetic mutations, and the drug is now being studied in several cancer types. I think it's going to work especially well in tumors that are primarily RAS driven, including colon cancer and lung cancer. It might also work in other cancer types in combination with drugs targeting other genetic mutations, but further research is needed.

Source: www.news-medical.net ↗
02What is carb cycling?

Carb cycling is an attempt to fine-tune your carbohydrate consumption to alter many aspects of your metabolism. Your plan will include the same protein intake each day but vary carbohydrates according to your activity. Your carb cycling plan may have three low or zero carb days, two moderate carb days, and two high carb days. Meeting your calorie requirements will require including more fats on low-carb days. Carb cycling needs much more planning than a usual calorie-controlled diet. One way is to match your carb cycling to your physical activity. If you go to the gym thrice a week, you could have carbs on those days. The carbs provide energy for your workout, prevent fatigue, and avoid the muscle loss sometimes seen with dieting. The days when you eat little to no carbs force your body to generate energy from other sources, like proteins and fats. But the days when you eat more carbohydrates might reverse this change. You must only eat a high-carb diet on the days you have a heavy workout, which uses up the calories.

Source: www.medicinenet.com ↗
03Can you please give an overview of BenevolentBio?

What we're trying to do here at Benevolent is develop systems and processes that allow us to tap into the huge amount of public information and some propriety databases that we have paid to access and through that, generate hypotheses which our scientists can then triage. We've got over ten times the amount of information in our database at present (and it’s growing) than we believe that companies such as Watson have. Bringing that and filtering the signals from the ‘noise’ to our experienced drug discovery chemists and biologists, means, firstly, we can reduce the amount of time we take to triage new hypotheses, and secondly, we can develop more predictive chemical tools to allow us to make better molecules and also to reposition existing molecules for new indication.

Source: www.news-medical.net ↗
04In safety assessment, the consequences of being wrong are significant. How do you think about uncertainty and model limitations for safety and discovery?

Uncertainty and model limitations are critical in safety assessment. There is clearly greater potential for animal or human harm from an incorrect safety assessment than from making the wrong molecule in early discovery, although uncertainty matters in both contexts. It is important to distinguish different types of uncertainty. Aleatoric uncertainty reflects irreducible randomness in a task, while epistemic uncertainty is model-related, such as hallucinations or lack of knowledge. For LLM systems, we use multiple methods to measure consistency and we have built fact-checking approaches in which a separate LLM independently verifies the primary engine's outputs. For QSAR models, including our SAR work around seizure liability, we can use statistical metrics such as confidence intervals to quantify and communicate uncertainty. Understanding that uncertainty exists and communicating it in both safety and discovery is critical. Uncertainty metrics tell us where potential blind spots may exist in our modelling allowing us to take action to improve over time. This applies to both safety and discovery. The aim is not to pretend AI removes uncertainty, but to make uncertainty visible so scientists can make better-informed decisions. Download the Full PDF to Revisit James McDonagh's Insights on AI in Drug Safety Discovery

Source: www.news-medical.net ↗
05Are supplements necessary?

Daily, if you eat a balanced diet that includes healthy foods, you technically should not need a vitamin supplement. A healthy diet incorporates lean proteins, healthy fats, grains, fruits, and vegetables. But if you do not have a balanced diet, you may be considering hair, skin, and nail vitamins. Some people prefer supplements, sometimes choosing a multivitamin that can supply all of your essential minerals and vitamins. But taking too much of vitamins or unnecessary supplements is wasteful because the body gets rid of excess vitamins and minerals or, worse, it can be dangerous. The following is a guide to choosing which vitamins you may want to consider supplementing and when. Deficiencies in the nutrients that keep the skin, hair, and nails healthy can cause changes over time. For example, not enough intake of vitamins A and E, along with not enough biotin, can cause scaly and rough skin patches, eczema, and hair loss. If there is a deficiency, vitamins will help. However, if there is no deficiency, there is no clear evidence that supplements will make a difference. No research studies concluded that supplements treat or prevent age-related, natural hair damage or loss or lead to healthier skin. Two studies in the early 1990s did suggest that a biotin supplement may cause the hair to become stronger and strengthen weak nails. However, the studies were small and not reproduced.

Source: www.medicinenet.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →